These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 205863)

  • 1. [Mechanisms of neuromuscular transmission disorder in rats with alloxan diabetes].
    Pushkarev IuP
    Probl Endokrinol (Mosk); 1978; 24(2):77-81. PubMed ID: 205863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of disturbance in neuromuscular transmission in rats with alloxan diabetes.
    Pushkarev YP
    Neurosci Behav Physiol; 1980; 10(3):216-9. PubMed ID: 6251400
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electrophysiological analysis of myoneural synaptic transmission in rats with apparent alloxan diabetes].
    Voronina LI; Pushkarev IuP
    Probl Endokrinol (Mosk); 1973; 19(6):95-8. PubMed ID: 4358327
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanisms of inhibition of synaptic transmission in the sympathetic ganglia of rats with alloxan diabetes].
    Pushkarev IuP
    Biull Eksp Biol Med; 1978 Sep; 86(9):272-4. PubMed ID: 212135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the function of the spinal cord monosynaptic apparatus in rats with manifest alloxan diabetes].
    Pushkarev IuP
    Probl Endokrinol (Mosk); 1978; 24(4):64-7. PubMed ID: 683974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous transmitter release in experimental neuromuscular disorders of the rat.
    Thesleff SW
    Muscle Nerve; 1982; 5(9S):S12-6. PubMed ID: 6302487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular transmission in the murine mutants "motor end-plate disease" and "jolting".
    Harris JB; Pollard SL
    J Neurol Sci; 1986 Dec; 76(2-3):239-53. PubMed ID: 3025377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acute alloxan diabetes on the sensitivity of the rat skeletal neuromuscular junction to drugs.
    Schofield GG; Furman BL; Marshall IG
    Acta Diabetol Lat; 1978; 15(5-6):287-93. PubMed ID: 219652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology of the neuromuscular junction in diabetic rats.
    Constantini S; Schiller Y; Cohen AM; Rahamimoff R
    Isr J Med Sci; 1987; 23(1-2):101-6. PubMed ID: 3032845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular changes with alloxan hyperglycemia. Electrophysiological, biochemical, and histological study in rats.
    Hildebrand J; Joffroy A; Graff G; Coërs C
    Arch Neurol; 1968 Jun; 18(6):633-41. PubMed ID: 4297452
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuromuscular transmission in diabetes: response to high-frequency activation.
    Schiller Y; Rahamimoff R
    J Neurosci; 1989 Nov; 9(11):3709-19. PubMed ID: 2555457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vecuronium suppresses transmission at the rat phrenic neuromuscular junction by inhibiting presynaptic L-type calcium channels.
    Ji F; Han J; Liu B; Wang H; Shen G; Tao J
    Neurosci Lett; 2013 Jan; 533():1-6. PubMed ID: 23200725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presynaptic and postsynaptic actions of procainamide on neuromuscular transmission.
    Lee DC; Kim YI; Liu HH; Johns TR
    Muscle Nerve; 1983; 6(6):442-7. PubMed ID: 6312309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of diabetic complications on neuromuscular transmission in the smooth muscle of the bladder of rats with experimental diabetes].
    Vladimirova IA; Philyppov IB; Kulieva EM; Paduraru ON; Shuba YY; Shuba YM
    Fiziol Zh (1994); 2015; 61(4):56-62. PubMed ID: 26552306
    [No Abstract]   [Full Text] [Related]  

  • 15. X-radiation actions on the neuromuscular transmission.
    Portela A; de Xamar Oro JR; Stewart PA; Gimeno AL; Guardado I; Brennan M; Llobera OH; Pérez JC
    Acta Physiol Lat Am; 1977; 27(4):157-76. PubMed ID: 214995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects of beta-amyloid25-35 peptide aggregates on transmitter release in neuromuscular synapses.
    Garcia N; Santafé MM; Tomàs M; Lanuza MA; Tomàs J
    J Neuropathol Exp Neurol; 2008 Mar; 67(3):250-9. PubMed ID: 18344916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of hydrogen sulfide (H2S) action on synaptic transmission at the mouse neuromuscular junction.
    Gerasimova E; Lebedeva J; Yakovlev A; Zefirov A; Giniatullin R; Sitdikova G
    Neuroscience; 2015 Sep; 303():577-85. PubMed ID: 26192092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):112-9. PubMed ID: 6245355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Postsynaptic membrane sensitivity to acetylcholine during blockade of excitatory transmission from nerve to skeletal muscle during long-term low-frequency transmission].
    Nikol'skiĭ EE; Poletaev GI
    Neirofiziologiia; 1975; 7(5):550-6. PubMed ID: 174016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular junction defect in diabetes.
    Miglietta O
    Diabetes; 1973 Sep; 22(9):719-23. PubMed ID: 4353851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.